All companies, by market cap
505 companies and 2079 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Revenue | Quarter |
|---|---|---|---|---|---|
| 276 |
|
$27.1B | $50.99 −1.1% | $20.9B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 FISV Fiserv |
| 277 |
|
$27.1B | $412.56 +1.1% | $5.0B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 CPAY Corpay |
| 278 |
|
$27.0B | $229.43 +1.4% | $8.0B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 WSM Williams-Sonoma |
| 279 |
|
$27.0B | $298.60 +2.0% | $1.7B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 VRSN Verisign |
| 280 |
|
$26.7B | $70.18 +1.6% | $14.9B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 OTIS Otis Worldwide |
| 281 |
|
$26.5B | $45.83 −0.7% | $15.5B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 FE FirstEnergy |
| 282 |
|
$26.4B | $172.02 +1.3% | $14.0B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 CINF Cincinnati Financial |
| 283 |
|
$26.3B | $237.89 +1.2% | $11.6B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 DGX Quest Diagnostics |
| 284 |
|
$25.8B | $274.99 +1.7% | $12.7B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 JBHT J.B. Hunt |
| 285 |
|
$25.8B | $1,285.75 −0.6% | $2.0B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 MTD Mettler Toledo |
| 286 |
|
$25.6B | $315.31 +1.2% | $14.3B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 LH Labcorp |
| 287 |
|
$25.5B | $189.15 +0.1% | $8.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 DOV Dover |
| 288 |
|
$25.5B | $38.65 −1.2% | $9.4B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 CNP CenterPoint Energy |
| 289 |
|
$25.4B | $33.79 −0.9% | $2.8B 1 of four quarters in a row 2026: Q1 | Q1 FY26 PPL PPL |
| 290 |
|
$25.2B | $365.27 −1.0% | $0.9B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 TPL Texas Pacific Land |
| 291 |
|
$25.2B | $193.61 +0.5% | $12.0B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 EXPD Expeditors International |
| 292 |
|
$25.1B | $107.49 +0.5% | $9.1B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 XYL Xylem |
| 293 |
|
$25.0B | $355.20 +2.6% | $3.3B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 WST West Pharmaceutical Services |
| 294 |
|
$24.9B | $218.57 +4.1% | $13.2B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 DRI Darden Restaurants |
| 295 |
|
$24.8B | $122.19 +0.6% | $5.4B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 INCY Incyte |
| 296 | Q S&P 500 Qnity Electronics Rank 296 S&P 500 Share price: $117.23 −7.3% Q2 FY26 Q Qnity Electronics | $24.5B | $117.23 −7.3% | $5.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 Q Qnity Electronics |
| 297 |
|
$24.3B | $187.03 +6.1% | $3.1B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 VRSK Verisk Analytics |
| 298 |
|
$23.9B | $90.19 +2.2% | $10.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 GPN Global Payments |
| 299 |
|
$23.6B | $548.65 +0.3% | $13.0B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ULTA Ulta Beauty |
| 300 |
|
$23.5B | $117.91 −0.5% | $8.0B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 TPR Tapestry |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.